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Primary aldosteronism is characterized by hypertension, hypokalemia, 
suppressed plasma renin activity (PRA) and autonomous aldosterone 
production [1,2]. Compared to patients with similar levels of hypertension, 
patients with primary aldosteronism have greater left ventricular 
hypertrophy (LVH) and increased rate of cardiovascular complications [3-5]. 
QT interval prolongation, which may increase the risk of life-threatening 
arrhythmias, is also often found in primary aldosteronism [6,7]. QT interval 
prolongation can result from hypokalemia as well as LVH [8-10]. In this 
study, we assessed whether hypokalemia or LVH represented the principal 
factor determining QT interval prolongation in patients with primary 
aldosteronism.  
 
The study population consisted of 52 patients with newly diagnosed primary 
aldosteronism. Primary aldosteronism was confirmed with captopril 
challenge test, furosemide plus upright test and / or salt loading test. These 
protocols have been previously described. Patients with bundle branch block, 
atrial fibrillation or ventricular pacing were excluded because these factors 
might affect QT interval. Patients receiving aldosterone antagonist, 
potassium supplementation or anti-arrhythmic drugs of any class including 
β-blockers were also excluded because these agents might affect serum 
potassium level or QT interval.  
Plasma renin activity (PRA) and plasma aldosterone concentration (PAC) 
were measured by radioimmunoassay as previously described. Blood was 
collected from an antecubital vein and serum potassium concentrations were 
measured using a standard ion electrode method. 
A 12-lead electrocardiogram (ECG) was recorded at a paper speed of 25 
mm/sec and an amplification of 10 mm/mV. The isoelectric line was defined 
as the level of the preceding TP segment. The QT interval was taken from 
the beginning of the QRS complex to the end of the downslope of the T wave 
(crossing of the isoelectric line). When T waves were inverted, the end was 
taken at the point where the trace returned to the isoelectric line. When U 
waves were present, the end of T wave was taken as the nadir between the T 
wave and the U wave. QT intervals were measured by one independent 
observer who was unaware of the clinical data of the patients. The QT 
interval considered for each patient was the maximum QT interval 
measured in any lead. To adjust QT interval for the heart rate, QTc interval 
was calculated according to Bazett’s formula: QTc interval (msec) = QT 
interval (msec) / RR1/2. Three ECG indexes for LVH were measured in each 
ECG: Sokolow-Lyon index (sum of S wave in V1 and R wave in V5), Cornell 
voltage index (sum of R wave in aVL and S wave in V3), and Gubner index 
(sum of R wave in I and S wave in III) [11-13].  
Transthoracic echocardiographic data were obtained on admission using a 
commercial ultrasound machine. Two-dimensional guided M-mode 
measurements of left ventricular end-diastolic diameter (LVDD), 
interventricular septum thickness (IVS) and posterior wall thickness (PW) 
were measured. Left ventricular mass was calculated using the formula of 
Deverreux and Reichek: left ventricular mass (g) 
=1.04[(LVDD+IVS+PW)3-(LVDD)3]-13.6. Left ventricular mass (LVM) index 
was calculated by dividing LVM by body surface area [14-16]. 
Statistical analysis was performed with chi-square and Student’s t- tests. 
Relations between variables were determined by linear regression analysis. 
All data are expressed as mean±SD. Differences were considered significant 
if the p value was <0.05.  
 
Patient characteristics are shown in Table 1. There were 26 male and 26 
female patients with a mean age of 59±11 years. PRA and PAC were 0.51±
0.37 ng/ml/hr and 27.6± 22.6 pg/ml, respectively. Serum sodium and 
potassium were 140.9±3.3 mEq/l and 3.7±0.6 mEq/l, respectively. QTc 
interval was 424.1±24.5 msec.  
In 18 patients (35%), serum potassium level was less than 4.0 mEq/l. There 
was a significant correlation between serum potassium level and QTc 
interval (r=-0.45, p<0.001, Figure 1). On the other hand, PAC did not 
correlate significantly with QTc interval (r=0.006, p=0.97). There was no 
significant correlation between LVM index and QTc interval (r=0.18, p=0.21, 
Figure 2). Three ECG parameters also did not correlate significantly with 
QTc interval (Sokolow-Lyon index, r=0.10, p=0.47; Cornell voltage index, 
r=0.15, p=0.30; Gubner index, r=0.05, p=0.73).  
 
Several reports have shown that QT interval prolongation is associated with 
the risk of life-threatening arrhythmias in patients with primary 
aldosteronism [17,18]. Hypokalemia is known to cause QT interval 
prolongation. However, it remains to be controversial whether QT interval is 
associated with serum potassium level in patients with primary 
aldosteronism. Matsumura et al previously reported that QTc interval 
significantly correlated with serum potassium level, but did not with PAC in 
19 patients with primary aldosteronism [6]. They also showed that this 
correlation disappeared after adrenalectomy. On the other hand, Yang et al 
reported that QT interval correlated with PAC, but did not potassium level in 
patients with 26 patients with primary aldosteronism [7]. One possible 
reason of the discrepancy between their studies was a small sample size. In 
this study, we evaluated in a relatively large number of 56 patients, and 
demonstrated that QTc interval significantly correlated with serum 
potassium level, but did not with PAC. Our results suggested that 
aldosterone excess itself did not affect the QTc interval.  
Previous studies showed that QT interval was associated with LVH in 
hypertensive patients [8,9] or diabetic subjects [10]. Although LVH of the 
concentric type is common in primary aldosteronism, there has been no 
report assessing this correlation in this disorder. In this study, we showed 
that there was no significant correlation between QT interval and 
echocardiographic as well as electrocardiographic LVH. As shown in this 
study, QT interval prolongation in primary aldosteronism seems to be 
associated with serum potassium level rather than LVH. Because QT 
interval prolongation may potentially increase the risk of life-threatening 
arrhythmias, clinician should pay careful attention to serum potassium level 
and QT interval in patients with primary aldosteronism.  
In conclusion, QT interval prolongation was associated with serum 
potassium level rather than LVH in patients with primary aldosteronism. 
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FIGURE LEGENDS 
Figure 1 There was a significant correlation between serum potassium level 
and QTc interval (r=-0.45, p<0.001). 
 
Figure 2 There was no significant correlation between LVM index and QTc 
interval (r=0.18, p=0.21). 


Age (years) 59±11
Male gender 26 (50%)
Systolic blood presure (mmHg) 144±19
Diastolic blood pressure (mmHg) 85±12
Plasma renin activity (ng/ml/hr) 0.51±0.37
Plasma aldosterone concentration (pg/ml) 27.6±22.6
Serum sodium (mEq/l) 140.9±3.3
Serum potassium (mEq/l) 3.7±0.6
Serum creatinine (mg/dl) 0.82±0.28
Electrocardiographic findings
  QTc interval (msec) 424.1±24.5
  Sokolow-Lyon index (mm) 30.8±9.0
  Cornell voltage index (mm) 16.9±7.9
  Gubner index (mm) 8.6±4.8
Echocardiographic findings
  Left ventricular end-diastolic diameter (mm) 47.7±7.7
  Left ventricular ejection fraction (%) 65.0±5.1
  Left ventricular mass index (g/m2) 118.7±34.2
  Left atrial diameter (mm) 37.7±5.7
Table 1 Patient characteristics
